Scholarlink

<p><i>Aeromonas hydrophila</i> (<i>A. hydrophila</i>) is widely spread in different aquatic environments and still poses a serious threat to the health of aquatic animals. Nevertheless, with the emergence of drug-resistant <i>A. hydrophila</i>, antibiotics have shown limited efficacy as primary therapeutic agents, and novel treatment strategies are urgently needed. The increasing understanding of anti-virulence and anti-quorum-sensing (QS) strategies offers new hope for drug discovery against <i>A. hydrophila</i> infections, which aim not to inhibit or kill bacteria but to reduce pathogenicity by reducing the production or activity of virulence factors. Here, xanthoxylin was screened out, and some tests were conducted on virulence phenotypes and therapeutic effects; the results demonstrated that xanthoxylin lacked anti-<i>A. hydrophila</i> effect could reduce the levels of QS-mediated virulence factors and the transcription of the <i>aerA</i>, <i>ahyR</i>, and <i>ahyI</i> genes. Further therapeutic results showed that xanthoxylin could protect A549 cells from cytotoxicity induced by aerolysin and improve the survival rate of crucian carp (<i>Carassius auratus gibelio</i>) challenged with <i>A. hydrophila</i>. Therefore, xanthoxylin could be a potential QS inhibitor for controlling <i>A. hydrophila</i> infections in aquaculture.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Xanthoxylin as a quorum-sensing inhibitor of Aeromonas hydrophila with promising therapeutic effects

  • 期刊论文

  • 发表日期：

    2026年5月20日

查看全文
  • Shengping Li,
  • Shun Zhou,
  • Xiaohui Ai,
  • Jing Dong

摘要

Aeromonas hydrophila (A. hydrophila) is widely spread in different aquatic environments and still poses a serious threat to the health of aquatic animals. Nevertheless, with the emergence of drug-resistant A. hydrophila, antibiotics have shown limited efficacy as primary therapeutic agents, and novel treatment strategies are urgently needed. The increasing understanding of anti-virulence and anti-quorum-sensing (QS) strategies offers new hope for drug discovery against A. hydrophila infections, which aim not to inhibit or kill bacteria but to reduce pathogenicity by reducing the production or activity of virulence factors. Here, xanthoxylin was screened out, and some tests were conducted on virulence phenotypes and therapeutic effects; the results demonstrated that xanthoxylin lacked anti-A. hydrophila effect could reduce the levels of QS-mediated virulence factors and the transcription of the aerA, ahyR, and ahyI genes. Further therapeutic results showed that xanthoxylin could protect A549 cells from cytotoxicity induced by aerolysin and improve the survival rate of crucian carp (Carassius auratus gibelio) challenged with A. hydrophila. Therefore, xanthoxylin could be a potential QS inhibitor for controlling A. hydrophila infections in aquaculture.